As White House Presses for Booster Shots, Americans Are Slow to Get Them
BALTIMORE — The new coronavirus booster shots have found a modest number of takers at …
BALTIMORE — The new coronavirus booster shots have found a modest number of takers at …
WASHINGTON — Federal regulators broadened access to updated coronavirus booster shots on Wednesday to include …
British regulators on Monday approved the country’s first Covid-19 booster vaccine to target two coronavirus …
The Food and Drug Administration on Wednesday authorized the first redesign of coronavirus vaccines since …
The Centers for Disease Control and Prevention on Friday recommended Moderna’s coronavirus vaccine be used …
The vaccines seem safe for children and are likely to protect against severe illness. But data on efficacy are thin, and most children have already been infected.
The advisers are all but guaranteed to vote yes, despite reservations about the paucity of data, especially regarding the efficacy of the Pfizer-BioNTech vaccine.
Some scientists believe that a clearer picture of Covid vaccine efficacy could have emerged sooner if investigators had tracked certain immune cells, not just antibodies.
States have already ordered millions of doses; if the agency authorizes them in the coming days, babies, toddlers and preschoolers could start receiving shots next week.
Neither Pfizers nor Modernas pediatric doses have been tested against the subvariants that may soon be dominant in the U.S.
Outside experts will make their recommendations this week on how the agency should rule on applications from Pfizer and Moderna to vaccinate the nations youngest children.
A significantly stronger immune response against Omicron is seen, but it remains unclear how an updated vaccine will fare against future versions of the virus.
The findings indicate that the updated vaccine produced a significantly stronger immune response against Omicron, but it is unclear how it will fare against future versions of the virus.
Antibody levels rose in the children who received it, suggesting the vaccine protects against infection. But the data were gathered before the arrival of Omicron.
Both Moderna and Pfizer-BioNTech have asked the agency to approve their vaccines for children under 5.